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ABSTRACT 
 
Aims: To assess lipid peroxidation and enzymatic antioxidants in breast cancer patients attending 
Usmanu Danfodiyo University Teaching Hospital, Sokoto-Nigeria. 
Study Design: A cross-sectional study was conducted in which patients with confirmed cases of 
breast cancer and age-and gender-matched apparently healthy individuals were studied.  
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Place and Duration of Study: Breast Cancer Clinic, Usmanu Danfodiyo University Teaching 
Hospital, Sokoto and Department of Chemical Pathology, Faculty of Medical Laboratory Sciences, 
Usmanu Danfodiyo University, Sokoto, between January, 2015 and December, 2015. 
Methodology: We included forty six (46) each of breast cancer women and controls (age range 20 
to ≥70 years). Demographic and anthropometric data were obtained using questionnaires 
administered to each breast cancer patient and control. Serum activities of superoxide dismutase 
(SOD), catalase (CAT), glutathione Peroxidase (GPX) and serum concentration of malondialdehyde 
were estimated using standard techniques. 
Results: Result indicated significantly (p<0.001) lower serum activities of SOD (1.52±0.03 U/ml), 
CAT (1.57±0.09 U/ml) and GPX (10.25±0.29 nmol/min/ml), while MDA (21.07±0.93 µl) is 
significantly (p<0.001) higher in breast cancer patients compared with controls (3.54±0.06 U/ml, 
5.85±0.10 U/ml, 24.53±0.17 nmol/min/ml and 8.88±0.66 µl respectively). With the exception of 
serum SOD which is significantly (p<0.001) lower as the cancer progresses from stage I to IV, 
serum activities of CAT, GPX and concentration of MDA were not significantly (p>0.05) different 
between the stages of the breast cancer. Serum SOD (1.47±0.04 U/ml), CAT (1.39±0.10 U/ml) and 
GPX (9.53±0.23 nmol /min/ml) were significantly (p<0.05, p<0.01 and p<0.001 respectively) lower, 
while MDA did not differ significantly (p>0.05) among the breast cancer patients on therapy 
compared with those not on therapy (1.62±0.07 U/ml, 1.99±0.17 U/ml and 12.07±0.54 nmol/min/ml 
respectively).  
Conclusion: This study demonstrates that, the breast cancer patients are oxidatively stressed as 
evidenced by the lower serum activities of antioxidant enzymes and higher malondialdehyde 
concentration. It is recommended that, breast cancer patients be supplemented with antioxidants in 
order to prevent the oxidative onslaught by free radicals. 
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1. INTRODUCTION 
 
Breast cancer is the second leading cause of 
death after lung cancer [1] and is the most 
common type of cancer in women and accounts 
for the highest morbidity and mortality worldwide 
[2,3]. It is second to cancer of the cervix in the 
North-Western geopolitical zone of Nigeria and 
also leading in the South-Western geopolitical 
zone [4,5]. 
 
Oxidative stress resulting from excessive 
production of reactive oxygen species (ROS) 
and/or decreased antioxidant capacity in the 
target cells and tissues has been suggested to 
play a crucial role in the initiation of DNA damage 
which might ultimately lead to carcinogenesis 
[5,6,7,8]. Major classes of biomolecules, 
including proteins, lipids and nucleic acids can be 
modified by ROS, with changes in their molecular 
structure and function [9]. The main targets of 
ROS are the polyunsaturated fatty acids located 
in the cell membranes and their oxidation results 
in lipid peroxidation. Lipid peroxidation in breast 
cancer has previously been reported [7,10]. 
 
Various cellular defense mechanisms, consisting 
of non-enzymatic antioxidants (vitamins A, C, E 
and glutathione) and enzymatic (SOD, CAT and 
GPX) are involved in the control of the 
debilitating effects of ROS production [11]. 
 
The increasing global incidence of breast cancer 
also emphasizes the need to understand the 
various mechanisms involved in breast 
tumourigenesis. However, no previous studies 
have evaluated lipid peroxidation and antioxidant 
enzymes activities in breast cancer women of 
African descent in Sokoto, Nigeria. Therefore, 
the current study measured the serum activities 
CAT, SOD, GPX and MDA in breast cancer 
women in Sokoto, Nigeria. 
 
2. MATERIALS AND METHODS 
 
2.1 Study Subjects and Study Area 
 
A total of ninety two (92) subjects were included 
in the study. These comprised of 46 women with 
histologically confirmed cases of breast cancer 
age range 20 to ≥70 years and 46 age- and 
gender-matched apparently healthy women 
monitored as controls. Eligibility criteria for the 
patients were histologically confirmed breast 
cancer patients who have started treatment for 
the tumour, those that were not yet on cancer 
treatment. Subjects were ineligible if they are 
known diabetes, liver or renal dysfunction 
  
 
 
Yeldu et al.; ARRB, 14(3): 1-8, 2017; Article no.ARRB.34672 
 
 
 
3 
 
(assessed by preliminary screening). The breast 
cancer patients attending the Breast Clinic of 
Usmanu Danfodiyo University Teaching Hospital 
(UDUTH), Sokoto were enrolled in the study. 
Sokoto State is located in the North-Western 
Nigeria. It shares borders with Kebbi State (West 
and South-East), Zamfara State to the West and 
Niger Republic to the North. Report from the 
2013 projection indicated that the state had a 
population of 4.6 million [12].  
 
2.2 Study Design  
 
A cross-sectional study in which patients with 
confirmed cases of breast cancer and age-and 
gender-matched apparently healthy individuals 
were studied. Qualitative and quantitative data 
were obtained using standard techniques. 
Confirmed cases of breast cancer patients were 
consecutively enrolled from the population of 
breast cancer patients that attended Breast Clinic 
UDUTH, Sokoto. The breast cancer patients 
were selected with the help of a Consultant 
Surgeon in the Breast Clinic based on the 
satisfaction of the study inclusion criteria.  
 
2.3 Ethical Approval 
 
Ethical approval for the study was obtained from 
the Ethics and Research Committee of Usmanu 
Danfodiyo University Teaching Hospital 
(UDUTH), Sokoto. Written informed consent was 
obtained from all study participants before 
enrollment. 
 
2.4 Blood Samples Collection and 
Processing 
 
Blood specimens (about 5 ml each) were taken 
into plain vacutainer tubes by venepuncture from 
a prominent vein. The blood specimen were 
allowed to clot and later centrifuged at 3000 rpm 
and the sera were carefully harvested into serum 
bottles and rapidly stored at -20°C until used for 
biochemical analysis. 
 
2.5 Measurement of Anthropometric 
Parameters 
 
Subjects were weighted with minimum clothing to 
the nearest 0.1 kg by using a regularly calibrated 
weighing health scale; model ZT 120 
(manufactured by Seca Gmbh and Co., 
Germany), while the heights were measured by 
using a calibrated Stadiometer, model 220 
(manufactured by Seca Gmbh and Co., 
Germany). Body mass index (BMI) for each 
subject was calculated using the following 
formula: BMI (kg/m2) = Body Weight (kg)/Height 
(m2).  
 
2.6 Estimation of Biochemical Analytes 
 
Serum activities of SOD, CAT and GPX were 
assayed by the methods of [13,14,15,16] using 
assay Kits procured from Enzo Life Sciences 
International, Inc. 5120 Butler Pike, Plymouth 
Meeting, USA. Serum malondialdehyde 
concentration was estimated by the method of 
[17] using Lipid hydroperoxide (LPO) assay kit 
procured from Cayman Chemical Company, Ann 
Arbor, Michigan, USA. 
 
2.7 Data Analysis 
 
The data obtained were analyzed using Microsoft 
Office Excel 2007 and Statistical Package for 
Social Sciences (SPSS) version 20. Results 
were expressed as mean ± SEM. Group 
comparisons were made using one-way analysis 
of variance (ANOVA), paired comparisons were 
carried out using the Student’s t-test. P-value of 
equal to or less than 0.05 (p ≤ 0.05) was 
considered as significant. 
 
3. RESULTS  
 
The demographic and socio-economic 
characteristics of and breast cancer patients and 
controls (Table 1) indicated that breast cancer 
occur in women mostly within the age group of 
40-49 years (45.7%), most of them were married 
(95.7%) with no formal education (52.2%) or 
unemployed (58.7%).  
 
The anthropometric parameters of breast cancer 
patients and controls are presented in Table 2. 
The result indicated no significant (p>0.05) 
differences in the anthropometric parameters 
between the breast cancer patients and control.  
 
The result of serum activities of antioxidant 
enzymes and malondialdehyde concentration 
among breast cancer patients and controls is 
presented in Fig. 1. The result indicated 
significantly (p<0.001) lower serum activities of 
SOD (1.52 ± 0.03 U/ml), CAT (1.57 ± 0.09 U/ml) 
and GPX (10.25 ± 0.29 nmol/min/ml), while 
serum MDA (21.07 ± 0.93 µl) is significantly 
(p<0.001) higher in breast cancer patients as 
compared with controls (3.54 ± 0.06 U/ml, 5.85 ± 
0.10 U/ml, 24.53 ± 0.17 nmol/min/ml and 8.88 ± 
0.66 µl respectively). 
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Table 1. Demographic and socio-economic characteristics of controls and patients 
 
Characteristics Controls Patients 
N=46 Percentage (%) N=46 Percentage (%) 
Age groups (years) 
    
     20-29 1 2.2 1 2.2 
     30-39 15 32.6 8 17.4 
     40-49 23 50.0 21 45.7 
     50-59 3 6.5 12 26.1 
     60-69 3 6.5 3 6.5 
     ≥70 1 2.2 1 2.2 
Marital status 
    
     Married 42 91.3 44 95.7 
     Single 1 2.2 0 0 
     Widowed 3 6.5 1 2.2 
     Divorced  0 0 1 2.2 
Tribe  
    
     Hausa  32 69.6 31 67.4 
     Yoruba  3 6.5 2 4.3 
     Fulani 6 13.0 7 15.2 
     Igbo 3 6.5 2 4.3 
     Others  2 4.3 4 8.7 
Education level 
    
     Tertiary  13 28.3 5 10.9 
     Secondary 7 15.2 10 21.7 
     Primary  9 19.6 7 15.2 
     Non-formal 17 37.0 24 52.2 
Occupation 
    
     Senior civil servant 6 13.0 4 8.7 
     Junior civil servant 9 19.6 4 8.7 
     Petty Trader 14 30.4 11 23.9 
     Unemployed 17 37.0 27 58.7 
Values are number (N) of subjects expressed as percentage (%) 
 
Table 2. Anthropometric parameters in breast cancer patients and controls 
 
Parameters Controls (n=46) Breast cancer patients (n=46) P- value 
Age (years) 42.43±1.14 45.37±1.23 0.083 
Weight (Kg) 61.43±0.85 57.94±1.90 0.100 
Height (m) 1.59±0.01 1.59±0.01 0.437 
BMI (Kg/m2) 24.19±0.37 23.05±0.78 0.188 
Values are mean ± standard error of mean; N = number of subjects; BMI = Body mass index; Level of 
significance is considered when p<0.05; significant differences were not observed when breast cancer patients 
were compared with controls 
 
Serum activities of antioxidant enzymes and 
malondialdehyde concentration among breast 
cancer patients based on cancer staging is 
presented in Table 3. The result indicated that, 
with the exception of serum SOD which 
decreased significantly (p<0.001) as the cancer 
progresses from stage I to IV, the serum 
activities of CAT, GPX and MDA concentration 
were not significantly (p>0.05) different between 
the stages of the breast cancer. 
 
Serum activities of SOD, CAT, GPX and MDA 
concentration among breast cancer patients 
based on presence or absence of cancer therapy 
(Table 4) indicated that, with the exception of 
serum MDA which did not differ significantly 
(p>0.05) between the breast cancer patients on 
therapy and those not on therapy, the serum 
SOD (1.47 ± 0.04 U/ml), CAT (1.39 ± 0.10 U/ml) 
and GPX (9.53 ± 0.23 nmol/min/ml) decreased 
significantly (p<0.05, p<0.01 and p<0.001 
respectively) among the breast cancer patients 
on therapy as compared with those not on 
therapy (1.62 ± 0.07 U/ml, 1.99 ± 0.17 U/ml and 
12.07 ± 0.54 nmol/min/ml respectively). 
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Fig. 1. Serum activities of antioxidant enzymes and malondialdehyde concentration in breast 
cancer patients and controls 
 
Table 3. Serum activities of antioxidant enzymes and malondialdehyde concentration among 
breast cancer patients based on cancer staging 
 
TNM classification 
(American Cancer 
Society, 2013) 
Antioxidant enzymes and malondialdehyde concentration 
SOD (U/ml) CAT (U/ml)  GPX (nmol/min/ml) MDA (µl) 
Stage I (n=3) 1.93±0.03 1.97±0.02 12.75±0.35 18.81±0.66 
Stage II (n=20) 1.68±0.02 1.43±0.11 10.43±0.43 20.52±1.70 
Stage III (n=16) 1.38±0.01 1.56±0.17 9.78±0.50 22.36±1.46 
Stage IV (n=7) 1.17±0.02 1.80±0.31 9.68±0.73 23.08±0.56 
P-Value 0.000 0.377 0.086 1.000 
Post Hoc Test, LSD 
Stage I vs  II 0.000 1.000 0.323 1.000 
Stage I vs III 0.000 1.000 0.099 1.000 
Stage I vs IV 0.000 1.000 0.141 1.000 
Stage II vs III 0.000 1.000 1.000 1.000 
Stage II vs IV 0.000 1.000 1.000 1.000 
Stage III vs IV 0.000 1.000 1.000 1.000 
Values are mean ± standard error of mean; n= number of subjects; SOD= Superoxide Dismutase; CAT= 
Catalase; GPX= Glutathione peroxidase; MDA= Malondialdehyde; Level of significance is considered when 
p≤0.05 
 
Table 4. Serum activities of antioxidant enzymes and malondialdehyde in breast cancer 
patients based on presence or absence of therapy 
 
Parameters                      Therapy P value 
Yes (n=33) No (n= 13)  
SOD (U/ml) 1.47±0.04 1.62±0.07 0.043 
CAT (U/ml) 1.39±0.10 1.99±0.17 0.003 
GPX (nmol/min/ml) 9.53±0.23 12.07±0.54 0.000 
MDA (µl) 20.86±1.12 21.61±1.70 0.720 
Values are mean ± standard error of mean; n= number of subjects; SOD= Superoxide Dismutase; CAT= 
Catalase; GPX= Glutathione peroxidase; MDA= Malondialdehyde; Level of significance is considered when 
p≤0.05 
0
5
10
15
20
25
30
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4. DISCUSSION 
 
The peak age of incidence of breast cancer was 
40-49 years (5th decade). This is in agreement 
with the findings from the studies conducted in 
South Africa [18], Ilorin, Nigeria [19] and Sudan 
[20] who reported the peak age of incidence of 
breast cancer at the 5th decade. Our result is in 
contrast with the report from Norway [21] and 
among the Philippines [22] in which the peak age 
of incidence were 6th and 8th decade respectively 
and also contrasted with the report from 
Khartoum –Sudan [23] where the peak age was 
above 50 years. The variation in the peak age of 
the breast cancer in women may be related to 
the onset of aetiopathogenesis of breast cancer 
which have been found to include, early 
menarche, late menopause, late age at first birth, 
and other reproductive factors [24]. 
 
The decreased serum activity of SOD is 
consistent with the results in Iran [25], India [26] 
and Egypt [27]. Lower serum activities of CAT 
corresponded to the findings of a study [25] in 
Iran; [26,28] in India; but contrasted with that of 
other study [29] who reported increased serum 
activities of CAT in breast cancer patients. The 
decreased serum activities of GPX in this study 
agreed with the finding of other study [30] who 
reported decrease in red blood cell GPX activity 
in breast cancer patients; but this contrasted with 
the report of previous studies [29,31] who 
independently reported increased in GPX 
activity. These conflicting findings in the activities 
of SOD, CAT and GPX may be due to 
differences in the enzymatic assay techniques 
used. 
 
The decreased in serum activity of SOD as the 
breast cancer progresses from stage I to stage 
IV is in agreement with the other study [29]. This 
may be due to increasing rate of generation and 
accumulation of ROS during the progression of 
breast cancer. Serum activities of CAT and GPX 
were similar between the breast cancer patients 
and controls which corroborated with previous 
study [26]. 
 
Cancer therapy appeared to be an important 
factor affecting antioxidant enzymes activities in 
breast cancer. The decreased serum activities of 
SOD, CAT and GPX observed in the current 
study agreed with the report of previous 
researchers [32,33] who reported lower SOD, 
CAT and GPX in breast cancer patients on 
chemotherapy. Cytotoxic drugs have been 
known to produce highly reactive free radicals 
(ROS) during chemotherapy treatment of cancer 
[33]. This explained the reason behind the 
decreased serum activities of antioxidant 
enzymes as they try to counteract the effects of 
these ROS in breast cancer patients that have 
started treatment for the cancer. The result of the 
present study also demonstrated an increase 
serum MDA in breast cancer patients as 
compared with controls. Oxidative stress 
resulting from enhanced lipid peroxidation in the 
tissue of patients with breast cancer as was 
demonstrated in the present study has been 
reported by other studies [34,35]. This may be 
the result of an imbalance between the 
antioxidant defence system and oxidant status, in 
favour of the oxidants that promoted the 
production of MDA. 
 
5. CONCLUSIONS 
 
The result confirmed the role of oxidative stress 
in breast cancer. Serum activities of SOD 
decrease as the breast cancer progresses from 
stage I to IV. This study also provides evidence 
that breast cancer patients undergoing therapy 
have lower serum activities of SOD, CAT and 
GPX compared to those not yet on therapy. 
Therefore levels of these antioxidants should be 
monitored periodically in breast cancer patients 
and antioxidant micronutrients supplementation 
along side with chemotherapy or radiotherapy is 
suggested. Further studies with more oxidative 
stress-related analytes are needed to explore      
the various mechanisms involved in breast 
tumorigenesis. 
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